Skip to content
← Holders

Squadron Capital Management LLC

What Squadron Capital Management LLC reported holding on Form 13F for the quarter ended Sep 30, 2026.

CIK 2050709 · Filed Nov 16, 2026

Positions
45
Reported value
$398.5M
Opened
21
Closed
19
Other managers included
0

Values are as the managers reported them, in dollars.Open the Form 13F on SEC EDGAR

Quarters on file

  1. Dec 31, 2025$236M
    33 positions
  2. Mar 31, 2026$272.9M
    37 positions
  3. Jun 30, 2026$322.2M
    43 positions
  4. Sep 30, 2026$398.5M
    45 positions
SecuritySharesChangeValueOf portfolio
KODKodiak Sciences Inc.
420K−16.0%$39.8M10%
CCCCC4 Therapeutics, Inc.
9.3M+29.4%$31M7.8%
COGTCogent Biosciences, Inc.
915K+5.8%$29.3M7.4%
KODKodiak Sciences Inc.Call option
270KNew$25.6M6.4%
SLNSilence Therapeutics plc
2.1MNew$22.8M5.7%
ZNTLZentalis Pharmaceuticals, Inc.
6.8M+84.5%$18.9M4.7%
EWTXEdgewise Therapeutics, Inc.
425K+46.6%$17.3M4.3%
RLAYRelay Therapeutics, Inc.
785K−19.1%$14.2M3.6%
ORICOric Pharmaceuticals, Inc.
1MNew$13.5M3.4%
RLMDRelmada Therapeutics, Inc.
3.5M−52.4%$13.2M3.3%
DFTXDefinium Therapeutics, Inc.
340K+300.0%$12.9M3.2%
PHVSPharvaris N.V.
400KNew$12.7M3.2%
ANLAdlai Nortye Group Ltd.
764.9K±0%$12.2M3.1%
VERAVera Therapeutics, Inc.
305KNew$9.8M2.5%
IVAInventiva S.A.
2.4M−1.4%$8.9M2.2%
IRONDisc Medicine, Inc.Call option
134.5K+348.3%$8.8M2.2%
COGTCogent Biosciences, Inc.Call option
265KNew$8.5M2.1%
AVTXAvalo Therapeutics, Inc.
450KNew$6.9M1.7%
ACRSAclaris Therapeutics, Inc.
1.2MNew$6.3M1.6%
RZLTRezolute, Inc.Call option
1.3M+47.1%$5.5M1.4%
ASMBAssembly Biosciences, Inc.
225K+40.6%$5.3M1.3%
ADAGAdagene Inc.
1.6M+29.3%$5.2M1.3%
CBIOCrescent Biopharma, Inc.
350KNew$5.1M1.3%
YARWYarrow Bioscience, Inc.
225KNew$5.1M1.3%
ZURAZura Bio Ltd
1.2MNew$5M1.3%
TCGXTCGX Acquisition Corp.
370.2KNew$4.6M1.2%
CTNMContineum Therapeutics, Inc.
323.6K+24.5%$4.3M1.1%
AVBPArriVent BioPharma, Inc.Call option
142.5K−22.1%$4.3M1.1%
IKTInhibikase Therapeutics, Inc.
2M−33.3%$4.1M1%
PALIPalisade Bio, Inc.
3M±0%$4.1M1%
TNGXTango Therapeutics, Inc.
150KNew$3.7M0.9%
JANXJanux Therapeutics, Inc.
215KNew$3.7M0.9%
SVRASavara Inc
675KNew$3.5M0.9%
CTNMContineum Therapeutics, Inc.Call option
225KNew$3M0.8%
IRLAIRulya Therapeutics Inc.
90K+122.9%$2.8M0.7%
JTTTJATT III Acquisition Corp
250KNew$2.8M0.7%
SCYXScynexis Inc
515K−32.0%$2.5M0.6%
SLNSilence Therapeutics plcCall option
180KNew$2M0.5%
ALXOALX Oncology Holdings Inc
1.4MNew$1.9M0.5%
LPCNLipocine Inc.
810K±0%$1.8M0.4%
BIOABioAge Labs, Inc.Call option
250K±0%$1.8M0.4%
PEPGPepGen Inc.
600KNew$1.5M0.4%
CCCCC4 Therapeutics, Inc.Call option
400K±0%$1.3M0.3%
JATTJATT II Acquisition Corp.
65KNew$730.9K0.2%
ZNTLZentalis Pharmaceuticals, Inc.Call option
100K−76.5%$277K0.1%